What is Castle Biosciences's other accrued liabilities?

Castle Biosciences (CSTL) reported other accrued liabilities of $10.69M in Q1 2026.

How has Castle Biosciences's other accrued liabilities changed year-over-year?

Castle Biosciences's other accrued liabilities increased by 27.7% year-over-year, from $8.37M to $10.69M.

What is the long-term trend for Castle Biosciences's other accrued liabilities?

Over 5 years (2020 to 2025), Castle Biosciences's other accrued liabilities has grown at a 23.9% compound annual growth rate (CAGR), from $3.06M to $8.94M.

Castle Biosciences CSTL Other accrued liabilities

Other accrued liabilities at other companies

VeracyteVCYT

——

BillionToOne, Inc. BLLN

——

Tempus AI, Inc.TEM

——

Other financials

Income statement

See full

Revenue$83.7M-4.9%

Gross profit$63.1M-11.8%

Operating income-$18.4M+34.1%

Net income-$14.5M+43.8%

EPS (diluted)-$0.49+45.6%

Balance sheet

See full

Cash & equivalents$63.8M-28.9%

Total debt$36.7M+42.1%

Total equity$461.4M+4.8%

Total assets$547.8M+9.2%

Cash flow

See full

Operating cash flow-$22.1M-267%

CapEx$12.5M+163%

Free cash flow-$34.6M-221%

Valuation

See full

Market cap$694.86M+29.9%

Enterprise value$667.82M+41.8%

P/S2×+0.5×

Profitability

See full

Gross margin77.9%-4.1pp

Operating margin-9.8%-30.8pp

Net margin-3.8%-10.2pp

FCF margin1.3%-10.7pp

Returns & leverage

See full

Return on equity-2.8%-10.6pp

Debt / equity0.1×0.0×

Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Castle Biosciences's other accrued liabilities?: Castle Biosciences (CSTL) reported other accrued liabilities of $10.69M in Q1 2026.
How has Castle Biosciences's other accrued liabilities changed year-over-year?: Castle Biosciences's other accrued liabilities increased by 27.7% year-over-year, from $8.37M to $10.69M.
What is the long-term trend for Castle Biosciences's other accrued liabilities?: Over 5 years (2020 to 2025), Castle Biosciences's other accrued liabilities has grown at a 23.9% compound annual growth rate (CAGR), from $3.06M to $8.94M.